KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcosa (ACA) Cost of Revenue (2017 - 2025)

Arcosa's Cost of Revenue history spans 9 years, with the latest figure at $552.9 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 2.9% year-over-year to $552.9 million; the TTM value through Dec 2025 reached $2.2 billion, up 8.83%, while the annual FY2025 figure was $2.2 billion, 8.83% up from the prior year.
  • Cost of Revenue for Q4 2025 was $552.9 million at Arcosa, down from $605.9 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $605.9 million in Q3 2025 and bottomed at $420.3 million in Q4 2022.
  • The 5-year median for Cost of Revenue is $485.8 million (2023), against an average of $493.7 million.
  • The largest annual shift saw Cost of Revenue dropped 5.1% in 2022 before it increased 20.29% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $442.9 million in 2021, then decreased by 5.1% to $420.3 million in 2022, then grew by 13.06% to $475.2 million in 2023, then rose by 13.07% to $537.3 million in 2024, then rose by 2.9% to $552.9 million in 2025.
  • Per Business Quant, the three most recent readings for ACA's Cost of Revenue are $552.9 million (Q4 2025), $605.9 million (Q3 2025), and $570.8 million (Q2 2025).